Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Mult Scler ; 27(4): 593-602, 2021 04.
Artigo em Inglês | MEDLINE | ID: mdl-32228283

RESUMO

BACKGROUND: Although cognitive problems have been identified in people with multiple sclerosis (PwMS), few studies have investigated the long-term change in cognitive functioning. OBJECTIVE: To identify trajectories of change in cognitive functioning for PwMS. METHODS: Participants enrolled in the quality-of-life subgroup from the Comprehensive Longitudinal Investigation of Multiple Sclerosis at Brigham and Women's Hospital (CLIMB) were eligible for our analysis. In 2006, participants in this group began to complete the Symbol Digit Modalities Test (SDMT) annually. Latent trajectory models were used to identify groups of participants with similar longitudinal change in SDMT scores. Linear and quadratic trajectory models were fit, and the models were compared. Latent trajectory models were also fit adjusting for baseline age and disease duration as well as using normalized SDMT scores. The groups identified across the approaches were compared. RESULTS: We found that classes with higher-than-average baseline values improved, classes with average baseline values remained relatively constant, and classes with lower baseline values experienced cognitive worsening. Similar results were observed in the alternative latent trajectory models accounting for other variables. CONCLUSION: Our models show that subjects with higher SDMT scores at baseline showed improvement, while subjects with lower SDMT scores at baseline showed worsening. Baseline age and disease duration were also associated with SDMT performance.


Assuntos
Transtornos Cognitivos , Esclerose Múltipla , Cognição , Feminino , Humanos , Testes Neuropsicológicos , Qualidade de Vida
2.
Ann Transplant ; 29: e941185, 2024 Apr 23.
Artigo em Inglês | MEDLINE | ID: mdl-38650316

RESUMO

Cytomegalovirus (CMV) infection is associated with increased morbidity and mortality in hematopoietic cell transplant (HCT) and solid organ transplant (SOT) recipients, with traditional anti-CMV therapies limited by their associated toxicities and the development of resistance. Clinical providers are often faced with challenging and complicated CMV infections that require multiple courses of antiviral therapies. Increasingly, advanced practice providers (APPs) are playing an important role in the day-to-day management of transplant recipients with CMV infection, including resistant/refractory CMV and other complex CMV syndromes. Here, we provide an overview of current preventative and treatment strategies for CMV infection in HCT and SOT recipients, highlighting the challenging aspects of current management and the potential utility of newer antiviral agents. This article also focuses on how a multidisciplinary team, orchestrated by APPs, can improve CMV-associated patient outcomes. Protocols using antiviral agents for the prevention or treatment of CMV infections require carefully designed and meticulously implemented strategies to ensure the best clinical outcomes for patients. APPs, who have increasingly become the frontline providers of outpatient care for transplant recipients, are ideally positioned to design and carry out these protocols.


Assuntos
Infecções por Citomegalovirus , Transplante de Células-Tronco Hematopoéticas , Transplante de Órgãos , Humanos , Antivirais/uso terapêutico , Infecções por Citomegalovirus/prevenção & controle , Infecções por Citomegalovirus/tratamento farmacológico , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Profissionais de Enfermagem , Transplante de Órgãos/efeitos adversos , Assistentes Médicos , Transplantados , Papel Profissional
3.
Tob Use Insights ; 15: 1179173X211069634, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35023981

RESUMO

BACKGROUND: Smoking behavior includes mechanisms taken on by persons to adjust for certain characteristic changes of cigarettes. However, as lung function declines due to lung-specific diseases, it is unclear how mechanical smoking behavior changes affect persons who smoke. We review two cases of patients who stopped smoking prior to and then subsequently resumed smoking after lung transplantation. METHODS: A retrospective review of two patients who were recipients of lung transplantation and sustained from cigarette usage prior to transplantation. RESULTS: Patient A was a 54-year-old woman who received a double lung transplant secondary to chronic obstructive pulmonary disease (COPD) in October 2017. She had stopped smoking cigarettes in July 2015 (FEV1 .56 L). Patient B was a 40-year-old man who received a double lung transplantation due to sarcoidosis in January 2015. He stopped smoking cigarettes in February 2012 (FEV1 1.15 L). Post-transplant, Patient A resumed smoking on March 2018 where her FEV1 was at 2.12 L (5 months post-transplantation), and Patient B resumed smoking in April 2017 where his FEV1 was 2.37 L (26 months post-transplantation). CONCLUSION: We report on two patients who resumed smoking after lung transplantation. While variations of smoking mechanics have been identified as a function of nicotine yield and type of cigarette, it lung mechanics may play a role in active smoking as well. Therefore, proper screening for tobacco usage post-lung transplantation should be considered a priority in order to preserve transplanted lungs.

4.
Transplantation ; 105(9): 2072-2079, 2021 09 01.
Artigo em Inglês | MEDLINE | ID: mdl-34075005

RESUMO

BACKGROUND: The impacts of COVID-19 on lung allograft function, rejection, secondary infection, and clinical outcomes in lung transplant recipients (LTRs) remain unknown. METHODS: A 1:2 matched case-control study was performed to evaluate rehospitalization, lung allograft function, and secondary infections up to 90 d after COVID-19 diagnosis (or index dates for controls). RESULTS: Twenty-four LTRs with COVID-19 (cases) and 48 controls were identified. Cases and controls had similar baseline characteristics and lung allograft function. LTRs with COVID-19 had higher incidence of secondary bacterial infection (29.2% versus 6.3%, P = 0.008), readmission (29.2% versus 10.4%, P = 0.04), and for-cause bronchoscopy (33.3% versus 12.5%, P = 0.04) compared with controls. At d 90, mortality in cases versus controls was 8.3% versus 2.1% (P = 0.21), incidence of invasive fungal infections in cases versus controls was 20.8% versus 8.3% (P = 0.13) and forced expiratory volume in 1 s (FEV1) decline ≥10% from baseline occurred in 19% of cases versus 12.2% of controls (P = 0.46). No acute cellular rejection, acute antibody-mediated rejection, or new donor-specific anti-HLA antibodies were observed among cases or controls within 90 d post index date. CONCLUSIONS: We found LTRs with COVID-19 were at risk to develop secondary infections and rehospitalization post COVID-19, compared with controls. While we did not observe post viral acute cellular rejection or antibody-mediated rejection, further studies are needed to understand if LTRs with COVID-19 who did not recover baseline lung function within 90 d have developed chronic lung allograft dysfunction stage progression.


Assuntos
COVID-19/epidemiologia , Rejeição de Enxerto/epidemiologia , Pneumopatias/cirurgia , Transplantados , Adulto , Idoso , Aloenxertos , Comorbidade , DNA Viral/análise , Feminino , Seguimentos , Humanos , Incidência , Pneumopatias/epidemiologia , Transplante de Pulmão , Masculino , Pessoa de Meia-Idade , Pandemias , Estudos Retrospectivos , Fatores de Risco , SARS-CoV-2/genética , Estados Unidos/epidemiologia
5.
J Can Chiropr Assoc ; 63(2): 111-118, 2019 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-31564749

RESUMO

BACKGROUND: Back pain is common during pregnancy and can have an adverse impact on the quality of life for some, yet treatment options for this population are limited. We document a chiropractic treatment that involves using kinesiology tape (tape) to help alleviate pregnancy-related back pain in two patients. CASE PRESENTATION AND MANAGEMENT: Two pregnant women reported to two different chiropractic offices with varying presentations of pregnancy-related back pain. A trial of chiropractic care was rendered in both chiropractic offices, which included the application of tape. OUTCOME AND DISCUSSION: In both case presentations, the addition of tape in the lumbosacral and/or abdominal regions, decreased pain intensity from 9-10/10 to 4/10 or less on the Numeric Rating Scale (NRS). Including a taping protocol to a plan of management in women with pregnancy-related LBP or PGP may be a safe and effective option to alleviate pain in this population.


CONTEXTE: Les maux de dos sont fréquents pendant la grossesse et peuvent avoir un impact négatif sur la qualité de vie de certaines femmes, mais les options de traitement pour cette population sont limitées. Nous documentons un traitement chiropratique qui implique l'utilisation de ruban de kinésiologie (ruban) pour aider à soulager les douleurs dorsales liées à la grossesse chez deux patientes. PRÉSENTATION ET GESTION DE CAS: Deux femmes enceintes se sont présentées à deux cabinets de chiropractie différents présentant des maux de dos différents liés à la grossesse. Un essai de soins chiropratiques comprenant l'application de ruban a été effectué dans les deux cabinets de chiropractie. RÉSULTATS ET DISCUSSION: Dans les deux présentations de cas, l'ajout de ruban dans les régions lombo-sacrées et/ou abdominales a diminué l'intensité de la douleur qui est passée de 9­10/10 à 4/10 ou moins sur l'échelle d'évaluation numérique (EEN). Le fait d'inclure un protocole d'utilisation de ruban à un plan de prise en charge chez les femmes présentant une lombalgie ou des douleurs pelviennes liées à la grossesse peut constituer une option sûre et efficace pour soulager la douleur chez cette population.

6.
Mult Scler Int ; 2019: 3584259, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31275652

RESUMO

OBJECTIVE: Cognitive impairment is a common symptom of multiple sclerosis (MS), yet treatment is currently limited. The primary goal of this pilot study was to assess the feasibility and acceptability of an at-home, five-week computerized speed of processing (SOP) training intervention for MS patients. In addition, we examined the utility of the intervention to improve speed of information processing, memory, executive function, and health-related quality of life (HRQOL). METHOD: Fifteen subjects were assigned five weeks of SOP training, two times per week, for a total of ten sessions. Subjects were trained on five computerized SOP tasks that required processing of increasingly complex visual stimuli in successively shorter presentation times. Subjects were given a neuropsychological test battery that included measures of speed of information processing, verbal memory, visual spatial memory, and executive function. Subjects were also administered patient-reported outcome (PRO) measures to assess HRQOL, depression, and work productivity. Neuropsychological and PRO batteries were completed at baseline and after five weeks. RESULTS: Eighty percent of subjects completed the five-week intervention (n = 12). Significant improvements were observed on some, but not all, measures of speed of information processing, verbal memory, and executive function. There were no significant changes in HRQOL. CONCLUSION: This pilot study supports the feasibility of an at-home SOP training intervention for individuals with MS. SOP training was associated with improvements in several cognitive domains. Larger, randomized controlled trials are warranted.

SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa